1. Home
  2. VREX vs RZLT Comparison

VREX vs RZLT Comparison

Compare VREX & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$10.98

Market Cap

447.2M

Sector

Technology

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$4.91

Market Cap

420.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
RZLT
Founded
2016
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
447.2M
420.8M
IPO Year
2016
2011

Fundamental Metrics

Financial Performance
Metric
VREX
RZLT
Price
$10.98
$4.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$16.67
$9.67
AVG Volume (30 Days)
466.3K
1.9M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.32
EPS
N/A
N/A
Revenue
$811,000,000.00
N/A
Revenue This Year
$5.35
N/A
Revenue Next Year
$3.88
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$1.07
52 Week High
$14.57
$11.46

Technical Indicators

Market Signals
Indicator
VREX
RZLT
Relative Strength Index (RSI) 57.73 53.68
Support Level $10.88 $2.91
Resistance Level $12.62 $5.42
Average True Range (ATR) 0.47 0.35
MACD 0.01 -0.02
Stochastic Oscillator 80.33 61.35

Price Performance

Historical Comparison
VREX
RZLT

About VREX Varex Imaging Corporation

Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: